e-learning
resources
Barcelona 2013
Sunday, 08.09.2013
Quality of diagnosis and assessment in primary care
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories
B. Stallberg, C. Janson, J. Sundh, S. Montgomery, M. Kämpe, E. Österlund Efraimsson, A. Ericson, K. Lisspers (Uppsala, Orebro, Falun, Sweden)
Source:
Annual Congress 2013 –Quality of diagnosis and assessment in primary care
Session:
Quality of diagnosis and assessment in primary care
Session type:
Poster Discussion
Number:
270
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
B. Stallberg, C. Janson, J. Sundh, S. Montgomery, M. Kämpe, E. Österlund Efraimsson, A. Ericson, K. Lisspers (Uppsala, Orebro, Falun, Sweden). New GOLD recommendations in a seven years follow up - changes in symptoms and risk categories. Eur Respir J 2013; 42: Suppl. 57, 270
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
Related content which might interest you:
COPD comorbidities and risk assessment according to GOLD 2011 revision
Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement
Year: 2013
Implementation of COPD phenotypes in real life
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
Three year follow-up of distribution and stability of patients with COPD according GOLD 2014
Source: International Congress 2015 – Clinical assessment in asthma and COPD
Year: 2015
2 years in the life of COPD patients: Evolution of GOLD 2011 classification in the ’real-life’ DACCORD study
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
GOLD and phenotypes: The new Czech COPD guidelines
Source: International Congress 2015 – Novel strategies for the management of asthma, COPD and airway infections
Year: 2015
High risk COPD patients cost less if treated according to GOLD 2011 recommendations
Source: Annual Congress 2013 –COPD diagnosis
Year: 2013
Outcomes in patients with COPD during a 3 year follow-up
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Longitudinal changes in COPD patients in primary care
Source: International Congress 2016 – In-patient and out-patient COPD management
Year: 2016
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines
Source: International Congress 2014 – Non inflammatory monitoring of airway diseases
Year: 2014
Evaluation of the GOLD 2011 severity criteria across the COPD spectrum
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
COPD: GOLD 2011 and implications for clinical practice
Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders
Year: 2013
Benefits of self-management education in COPD exacerbations
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
COPD severity analysis according to current evaluation criteria – National survey
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015
Disease burden in COPD patients in the first 24 months following diagnosis in a UK primary care setting
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013
Is an EXACT score applicable Japanese patients with COPD?
Source: Annual Congress 2013 –Respiratory nursing care: assessment, interventions and education
Year: 2013
Characterising patterns of prescribing for UK COPD patients with comorbidities or history of pneumonia
Source: International Congress 2014 – COPD exacerbations
Year: 2014
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study
Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations
Year: 2015
Collateral damage: Depressive symptoms in the spouses of COPD patients
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
The relationship between dyspnea and detection of depression in COPD patients (pts)
Source: International Congress 2015 – Different data in COPD
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept